Exercise for Prostate Cancer Patients (EXCAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00815672
Recruitment Status : Active, not recruiting
First Posted : December 30, 2008
Last Update Posted : December 15, 2017
United States Department of Defense
Information provided by (Responsible Party):
Karen Mustian, University of Rochester

Brief Summary:
The purpose of this study is to gain a better understanding of the mechanisms responsible for cancer-related fatigue.

Condition or disease Intervention/treatment Phase
Fatigue Behavioral: Exercise Not Applicable

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 122 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Supportive Care
Official Title: The Influence of Home-based Aerobic and Resistance Exercise on Cancer-Related Fatigue, Strength, and Muscle Mass in Prostate Patients.
Study Start Date : December 2007
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : December 2019

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
No Intervention: Treatment Arm 1
Usual Care: Standard care monitoring
Experimental: Treatment arm 2
Home-based Exercise: Progressive walking and resistance exercise treatment.
Behavioral: Exercise
Progressive walking and resistance exercise treatment

Primary Outcome Measures :
  1. Cancer-related fatigue [ Time Frame: 4.5 Months ]

Secondary Outcome Measures :
  1. To provide preliminary data on influence of home-based aerobic and resistance exercise on strength, skeletal muscle mass, inflammatory response, QOL and it's relationship to CRF [ Time Frame: 4.5 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   21 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Have a primary diagnosis of prostate cancer
  • Have a KPS of 60 or greater.
  • Be receiving any form of treatment for their prostate cancer or have received some form of treatment (e.g. surgery, chemotherapy, radiation therapy, hormone therapy) in the last 10 years
  • Have approval of physician and be able to read English.
  • Be 21 years of age or older and give informed consent

Exclusion Criteria:

  • Have bone metastases that preclude participation due to symptoms such as pain or location of the bone metastasis.
  • Have physical limitations that contraindicate participation.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00815672

United States, New York
James P. Wilmot Cancer Center, University of Rochester
Rochester, New York, United States, 14642
Sponsors and Collaborators
University of Rochester
United States Department of Defense
Principal Investigator: Karen Mustian, Ph.D. James P. Wilmot Cancer Center, University of Rochester

Responsible Party: Karen Mustian, Associate Professor, University of Rochester Identifier: NCT00815672     History of Changes
Other Study ID Numbers: 1703DOD
First Posted: December 30, 2008    Key Record Dates
Last Update Posted: December 15, 2017
Last Verified: December 2017

Keywords provided by Karen Mustian, University of Rochester:
Prostate cancer

Additional relevant MeSH terms:
Signs and Symptoms